MedTrace Logo

Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis

NCT03794505 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-01-08

No results posted yet for this study

Summary

Efficacy in pain and health related quality of life of suprascapular nerve block ultrasound guided and glenohumeral infiltration in glenohumeral arthritis

Conditions

  • Shoulder Arthritis

Interventions

DRUG

Methylprednisolone Acetate

depo-medrol 40 mg

DRUG

Lidocaine 2% Injectable Solution

2ml of 2% lidocaine

DRUG

Ropivacaine HCl Inj 7.5 MG/ML

25 mg

Sponsors & Collaborators

  • Instituto Mexicano del Seguro Social

    lead OTHER_GOV

Principal Investigators

  • Luis Alonso Calderon Cordova, MD · IMSS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-08-30
Completion
2018-08-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03794505 on ClinicalTrials.gov